Form 4: Bio-Path Holdings Director Paul Aubert Acquires Stock Options
SEC Form 4 Filing
Director Paul Aubert acquired options to purchase 2,000 shares of Bio-Path Holdings stock on July 30, 2024.
Summary
- On July 30, 2024, Paul Aubert, a director of Bio-Path Holdings, Inc., acquired options to purchase 2,000 shares of the company's common stock.
- The exercise price of the options is $1.55 per share.
- The options vest over a one-year period, with shares vesting in equal monthly increments based on continuing service to Bio-Path Holdings, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of insider activity. The option grant itself could be seen as a positive, but the filing is simply a factual report.
Positives
- The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, which is required when a company insider (such as a director or officer) buys or sells shares of the company's stock. It provides transparency into insider transactions.
Stakeholder Impact
- The acquisition of options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/30/2024 | Date of earliest transaction: Paul Aubert acquired stock options. |
| 07/31/2024 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, director, BIO-PATH HOLDINGS, BPTH, Aubert, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.